CC BY 4.0 · Endoscopy 2023; 55(S 01): E1043-E1044
DOI: 10.1055/a-2155-8235
E-Videos

Confocal laser endomicroscopy tears up the mask of protein-losing enteropathy

Jie Xu
1   Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Jiangsu, China
2   Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Jiangsu, China
,
Lili Cai
3   Digestive Endoscopy and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Jiangsu, China
,
Bota Cui
1   Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Jiangsu, China
2   Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Jiangsu, China
› Author Affiliations
Supported by: Natural Science Foundation of Jiangsu Province http://dx.doi.org/10.13039/501100004608 BK20211384
Supported by: 789 Outstanding Talent Program of SAHNMU 789ZYR20200802250

A 35-year-old man was admitted to the hospital with a history of edema and hypoproteinemia for 27 months. Laboratory analysis revealed severe hypoalbuminemia, with a serum albumin level of 1.25 g/dL (normal range 4–5.5 g/dL). Other laboratory and imaging examinations revealed hypoproteinemia with no evidence of protein loss due to renal, hepatic, or autoimmune disease. Capsule endoscopy was performed to confirm there were no lesions in the small intestine and no lesions were visible under white-light endoscopy ([Fig. 1]).

Zoom Image
Fig. 1 White-light endoscopic image showing the terminal ileum, with no obvious lesions visible.

A compromised epithelial barrier may lead to protein loss from the gut, but diagnosing lesions with a lack of significant subsurface mucosa is challenging. Therefore, after the patient had given written informed consent, we used probe-based confocal laser endomicroscopy (pCLE) to find clues with regard to albumin loss in the gut ([Video 1]). The probe of the pCLE was inserted through the channel of the colonoscope and the colon and terminal ileum were reached during colonoscopy. The image from the pCLE revealed a noticeable flow of fluorescein from the epithelial cells in the terminal ileum ([Fig. 2 a]), indicating that the mucosal barrier was damaged. In contrast, the center of the colonic crypt opening remained dark ([Fig. 2 b]), indicating the colonic mucosal barrier was intact [1]. Given the combination of the clinical symptoms, examination outcomes, and the results of pCLE, the patient was diagnosed with protein-losing enteropathy (PLE), which refers to a condition that is characterized by hypoproteinemia and edema in the absence of proteinuria [2].

Zoom Image
Fig. 2 Images during probe-based confocal laser endomicroscopy (pCLE) showing: a in the terminal ileum, fluorescein flowing out of the epithelial cells (arrow); b in the colon, no leakage of fluorescein into the crypt lumen (arrow).

After receiving prednisone acetate combined with azathioprine, the patient’s anasarca improved and his serum albumin level was restored. He has reported no recurrence of his symptoms and continues to have a normal level of serum albumin.

This case indicates that pCLE would be the perfect tool to diagnose PLE, with the specific characteristics of dynamically detecting the real-time mucosal barrier function at the subcellular level.

Video 1 Protein-losing enteropathy (PLE) is diagnosed via probe-based confocal laser endomicroscopy (pCLE) in a 35-year-old man.


Quality:

Endoscopy_UCTN_Code_TTT_1AQ_2AI

Endoscopy E-Videos
https://eref.thieme.de/e-videos

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos

Joint first authors




Publication History

Article published online:
15 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Rath T, Atreya R, Bodenschatz J. et al. Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in IBD: the prospective ERIca trial. Gastroenterology 2022; 164: 241-255
  • 2 Waldmann TA. Protein-losing enteropathy. Gastroenterology 1966; 50: 422-443